Drug intelligence / Profile preview

AllerPaste

Development stage: Unknown
Lead developer: AllerPops
Modality: Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Small Molecules, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
Administration: Topical

Overview

AllerPaste is a prebiotic toothpaste developed by AllerPops Corp. designed to support the oral microbiome and promote overall oral and immune health. It utilizes a traditional vegetable oil-based formula that combines the practices of oil-pulling and brushing. The formulation includes ingredients such as baking soda, arrowroot powder, sunflower oil, and arginine, which act as prebiotics to nourish beneficial oral bacteria without the use of harsh antibacterial chemicals. By maintaining a healthy balance of the oral microbiome, AllerPaste is intended to support immune system balance and lasting nasal and sinus health, often used in conjunction with AllerPops prebiotic lozenges.

Brand names: AllerPaste
Other names: AllerPaste toothpaste

Beyond the preview

Go deeper on AllerPaste.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on AllerPaste.

Explore the full profile